AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Activator protein-1 and nuclear factor-kappa B
Authors: Bennett, BL Manning, AM
Citation: Bl. Bennett et Am. Manning, Activator protein-1 and nuclear factor-kappa B, PROG R RES, 31, 2001, pp. 337-341
TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells
Authors: Schnabl, B Bradham, CA Bennett, BL Manning, AM Stefanovic, B Brenner, DA
Citation: B. Schnabl et al., TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells, HEPATOLOGY, 34(5), 2001, pp. 953-963
Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes
Authors: Schwabe, RF Bennett, BL Manning, AM Brenner, DA
Citation: Rf. Schwabe et al., Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes, HEPATOLOGY, 33(1), 2001, pp. 81-90
Electrolyte disorders
Authors: Manning, AM
Citation: Am. Manning, Electrolyte disorders, VET CLIN SM, 31(6), 2001, pp. 1289
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Authors: Bennett, BL Sasaki, DT Murray, BW O'Leary, EC Sakata, ST Xu, WM Leisten, JC Motiwala, A Pierce, S Satoh, Y Bhagwat, SS Manning, AM Anderson, DW
Citation: Bl. Bennett et al., SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase, P NAS US, 98(24), 2001, pp. 13681-13686
NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes
Authors: Aupperle, KR Bennett, BL Han, ZN Boyle, DL Manning, AM Firestein, GS
Citation: Kr. Aupperle et al., NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes, J IMMUNOL, 166(4), 2001, pp. 2705-2711
C-Jun N-terminal kinase is required for metalloproteinase expression, and joint destruction in inflammatory arthritis
Authors: Han, ZN Boyle, DL Chang, LF Bennett, B Karin, M Yang, L Manning, AM Firestein, GS
Citation: Zn. Han et al., C-Jun N-terminal kinase is required for metalloproteinase expression, and joint destruction in inflammatory arthritis, J CLIN INV, 108(1), 2001, pp. 73-81
NF-kappa B stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis
Authors: Hatano, E Bennett, BL Manning, AM Qian, T Lemasters, JJ Brenner, DA
Citation: E. Hatano et al., NF-kappa B stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis, GASTROENTY, 120(5), 2001, pp. 1251-1262
Inhibitor of nuclear factor kappa B kinase beta is a key regulator of synovial inflammation
Authors: Tak, PP Gerlag, DM Aupperle, KR Aupperle, KR van de Geest, DA Overbeek, M Bennett, BL Boyle, DL Manning, AM Firestein, GS
Citation: Pp. Tak et al., Inhibitor of nuclear factor kappa B kinase beta is a key regulator of synovial inflammation, ARTH RHEUM, 44(8), 2001, pp. 1897-1907
Evaluation of the survival prediction index as a model of risk stratification for clinical research in dogs admitted to intensive care units at four locations
Authors: King, LG Wohl, JS Manning, AM Hackner, SG Raffe, MR Maislin, G
Citation: Lg. King et al., Evaluation of the survival prediction index as a model of risk stratification for clinical research in dogs admitted to intensive care units at four locations, AM J VET RE, 62(6), 2001, pp. 948-954
Novel inhibitors of AP-1 and NF-kappa B mediated gene expression: Structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate
Authors: Palanki, MSS Erdman, PE Manning, AM Ow, A Ranson, LJ Spooner, D Suto, C Suto, M
Citation: Mss. Palanki et al., Novel inhibitors of AP-1 and NF-kappa B mediated gene expression: Structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)pyrimidine-5-carboxylate, BIOORG MED, 10(15), 2000, pp. 1645-1648
Inhibitors of NF-kappa B and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3 ',5 '-bis (trifluoromethyl)phenyl)carboxamide]
Authors: Palanki, MSS Erdman, PE Gayo-Fung, LM Shevlin, GI Sullivan, RW Suto, MJ Goldman, ME Ransone, LJ Bennett, BL Manning, AM
Citation: Mss. Palanki et al., Inhibitors of NF-kappa B and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3 ',5 '-bis (trifluoromethyl)phenyl)carboxamide], J MED CHEM, 43(21), 2000, pp. 3995-4004
The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis
Authors: Gerlag, DM Ransone, L Tak, PP Han, ZN Palanki, M Barbosa, MS Boyle, D Manning, AM Firestein, GS
Citation: Dm. Gerlag et al., The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis, J IMMUNOL, 165(3), 2000, pp. 1652-1658
The NF-kappa B system and drug discovery
Authors: Manning, AM
Citation: Am. Manning, The NF-kappa B system and drug discovery, LEUKOCYTE RECRUITMENT, ENDOTHELIAL CELL ADHESION MOLECULES, AND TRANSCRIPTIONAL CONTROL, 2000, pp. 303-321
Detection and purification of a multiprotein kinase complex from mammaliancells - IKK signalsome
Authors: Mercurio, F Young, DB Manning, AM
Citation: F. Mercurio et al., Detection and purification of a multiprotein kinase complex from mammaliancells - IKK signalsome, METH MOL B, 99, 2000, pp. 109-125
Inhibition of NF-kappa B
Authors: Suto, MJ Manning, AM
Citation: Mj. Suto et Am. Manning, Inhibition of NF-kappa B, HIGH THROUGHPUT SCREENING FOR NOVEL ANTI-INFLAMMATORIES, 2000, pp. 193-204
Regulation of NF-kappa B function - Novel molecular targets for pharmacological intervention
Authors: Mercurio, F Manning, AM
Citation: F. Mercurio et Am. Manning, Regulation of NF-kappa B function - Novel molecular targets for pharmacological intervention, CANC DRUG, 5, 2000, pp. 429-438
New targets for anti-inflammatory drugs
Authors: Lewis, AJ Manning, AM
Citation: Aj. Lewis et Am. Manning, New targets for anti-inflammatory drugs, CURR OP C B, 3(4), 1999, pp. 489-494
Gene-regulating protein kinases as important anti-inflammatory targets
Authors: Bhagwat, SS Manning, AM Hoekstra, MF Lewis, A
Citation: Ss. Bhagwat et al., Gene-regulating protein kinases as important anti-inflammatory targets, DRUG DISC T, 4(10), 1999, pp. 472-479
Interleukin-2 inhibitors in autoimmune disease
Authors: Palanki, MSS Manning, AM
Citation: Mss. Palanki et Am. Manning, Interleukin-2 inhibitors in autoimmune disease, EXPERT OP T, 9(1), 1999, pp. 27-39
Multiple signals converging on NF-kappa B
Authors: Mercurio, F Manning, AM
Citation: F. Mercurio et Am. Manning, Multiple signals converging on NF-kappa B, CURR OP CEL, 11(2), 1999, pp. 226-232
NF-kappa B as a primary regulator of the stress response
Authors: Mercurio, F Manning, AM
Citation: F. Mercurio et Am. Manning, NF-kappa B as a primary regulator of the stress response, ONCOGENE, 18(45), 1999, pp. 6163-6171
I kappa B kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex
Authors: Mercurio, F Murray, BW Shevchenko, A Bennett, BL Young, DB Li, JW Pascual, G Motiwala, A Zhu, HY Mann, M Manning, AM
Citation: F. Mercurio et al., I kappa B kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex, MOL CELL B, 19(2), 1999, pp. 1526-1538
Jun N-terminal kinase in rheumatoid arthritis
Authors: Han, ZN Boyle, DL Aupperle, KR Bennett, B Manning, AM Firestein, GS
Citation: Zn. Han et al., Jun N-terminal kinase in rheumatoid arthritis, J PHARM EXP, 291(1), 1999, pp. 124-130
Primary human CD4(+) T cells contain heterogeneous I kappa B kinase complexes: Role in activation of the IL-2 promoter
Authors: Khoshnan, A Kempiak, SJ Bennett, BL Bae, D Xu, WM Manning, AM June, CH Nel, AE
Citation: A. Khoshnan et al., Primary human CD4(+) T cells contain heterogeneous I kappa B kinase complexes: Role in activation of the IL-2 promoter, J IMMUNOL, 163(10), 1999, pp. 5444-5452
Risultati: 1-25 | 26-30